AstraZeneca reports 9% rise in Q3 2022 total revenue
Pharmaceutical Technology
NOVEMBER 11, 2022
AstraZeneca has reported an 11% rise in total revenue to $10.98bn in the third quarter (Q3) 2022 as against $9.87bn in the year-ago quarter. For the quarter ending on 30 September 2022, product sales were reported at $10.59bn from $9.7bn in Q3 last year, indicating a growth of 9%.
Let's personalize your content